Empresa Eidos Therapeutics, Inc.
Acciones
EIDX
US28249H1041
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 01/03/16 |
Jonathan Fox
PSD | President | 66 | 01/10/16 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/21 |
Jonathan Fox
PSD | President | 66 | 01/10/16 |
Neil Kumar
CEO | Chief Executive Officer | 45 | 01/03/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 38 872 893 | 12 835 887 ( 33,02 %) | 0 | 33,02 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,97 % | 108 mil M | |
+10,21 % | 105 mil M | |
+1,57 % | 23,46 mil M | |
-12,77 % | 21,72 mil M | |
-7,05 % | 18,64 mil M | |
-37,64 % | 17,45 mil M | |
-6,50 % | 17,19 mil M | |
+6,00 % | 13,99 mil M | |
+37,20 % | 12,53 mil M |